About Zymeworks (ZYME)
Zymeworks Inc. a clinical-stage biopharmaceutical company that is engaged in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The Company operates through a number of platforms, including Az... Read more
- USD8.65
- USD8.98
- USD8.65
- USD13.14
- -19.00%
- 76M
- 549.09k
- 516.96k
- 653M
- 6.02
- -13.10%
Stock News
40 minutes ago
KKR Real Estate Finance Trust Inc. Declares Preferred Stock Dividend
Yahoo
40 minutes ago
Universal Logistics Holdings, Inc. Named a 2023 Supplier of the Year by General Motors
Yahoo
50 minutes ago
Carnival Corporation & plc Announces Pricing of €500 Million 5.75% Senior Unsecured Notes Offering for Refinancing and Interest Expense Reduction and Successful Repricing of Senior Secured First Lien Term Loan B Facilities for Interest Expense and Debt Reduction
Yahoo
1 hour ago
UPDATE 1-Teamsters union files charges against PepsiCo with US labor board
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
